D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.36% |
| 2 | Consumer Discretionary | 9.47% |
| 3 | Financials | 6.95% |
| 4 | Healthcare | 6.38% |
| 5 | Communication Services | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Heritage Insurance Holdings
HRTG
$905M
| $1.06M | ﹤0.01% |
+99,188
| New | +$699K |
|
2927
Emergent Biosolutions
EBS
$377M
| $1.05M | ﹤0.01% |
416,664
-769,888
| -65% | -$1.74M |
|
2928
Brunswick
BC
$5.33B
| $1.05M | ﹤0.01% |
+10,892
| New | +$956K |
|
2929
Cullinan Oncology
CGEM
$1.07B
| $1.05M | ﹤0.01% |
61,621
+12,702
| +26% | +$196K |
|
|
BUJA
2930
DELISTED
Bukit Jalil Global Acquisition 1
BUJA
| $1.05M | ﹤0.01% |
100,000
| – | – |
|
2931
CALL
3D Systems Corp
DDD
$412M
| $1.05M | ﹤0.01% |
236,400
| – | – |
|
|
GOOS
2932
CALL
Canada Goose Holdings
GOOS
$903M
| $1.05M | ﹤0.01% |
86,900
| – | – |
|
2933
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$589M
| $1.04M | ﹤0.01% |
+30,080
| New | +$1.07M |
|
2934
CALL
Camping World
CWH
$399M
| $1.04M | ﹤0.01% |
37,300
-8,800
| -19% | -$227K |
|
2935
Vitamin Cottage Natural Grocers
NGVC
$744M
| $1.04M | ﹤0.01% |
57,358
+4,023
| +8% | +$64.6K |
|
|
SILK
2936
PUT
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.04M | ﹤0.01% |
+56,500
| New | +$897K |
|
|
KALV
2937
DELISTED
KalVista Pharmaceuticals
KALV
| $1.03M | ﹤0.01% |
87,093
-1,670
| -2% | -$22.3K |
|
2938
Tractor Supply
TSCO
$16.5B
| $1.03M | ﹤0.01% |
+19,700
| New | +$942K |
|
2939
Protagonist Therapeutics
PTGX
$8.8B
| $1.03M | ﹤0.01% |
+35,640
| New | +$970K |
|
2940
Kanzhun
BZ
$7.07B
| $1.03M | ﹤0.01% |
+58,726
| New | +$926K |
|
2941
Innospec
IOSP
$2.12B
| $1.03M | ﹤0.01% |
7,977
-2,031
| -20% | -$247K |
|
2942
CALL
Iovance Biotherapeutics
IOVA
$2.1B
| $1.03M | ﹤0.01% |
+69,400
| New | +$808K |
|
2943
Sportradar
SRAD
$4.38B
| $1.03M | ﹤0.01% |
88,359
-9,641
| -10% | -$102K |
|
2944
SiriusPoint
SPNT
$3.09B
| $1.03M | ﹤0.01% |
80,900
| – | – |
|
2945
Riskified
RSKD
$720M
| $1.03M | ﹤0.01% |
189,836
+131,707
| +227% | +$626K |
|
2946
CALL
LyondellBasell Industries
LYB
$18.8B
| $1.02M | ﹤0.01% |
10,000
-240,300
| -96% | -$23.4M |
|
|
LX
2947
LexinFintech Holdings
LX
$239M
| $1.02M | ﹤0.01% |
567,680
-38,809
| -6% | -$71.8K |
|
|
LPRO
2948
Open Lending Corp
LPRO
$373M
| $1.02M | ﹤0.01% |
163,115
-152,216
| -48% | -$1.12M |
|
2949
PUT
Titan Machinery
TITN
$458M
| $1.02M | ﹤0.01% |
+41,100
| New | +$1.07M |
|
2950
Costamare
CMRE
$1.86B
| $1.02M | ﹤0.01% |
89,750
+14,340
| +19% | +$159K |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co withdrew a net $8.58B in Q1 2024, closing 634 positions and reducing 1,722 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $307M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Arm worth $297M.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.